newsfilter
← Latest News
GlobeNewswire·

Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update

CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western study Fast Track Designation granted by FDA for CRB-701 to treat metastatic cervical cancerCRB 913 SAD/MAD obesity study expected to